Eli Lilly has unveiled plans to invest at least $27bn in building four new pharmaceutical manufacturing sites in the US.
Avtozma, which is Celltrion’s twelfth biosimilar to be approved by the EC, is a recombinant humanised monoclonal antibody ...
Just in time for Women’s History Month and International Women’s Day on March 8th, Medscape is proud to showcase its ...
Tired of the disconnect in virtual meetings? Discover how using webcams can enhance communication, build stronger relationships, and create a more engaging work environment.
The challenge for companies is to ensure their local affiliates meet local PV obligations while staying aligned with global PV requirements ...
Johnson & Johnson (J&J) has shared positive results from a late-stage study evaluating a subcutaneous (SC) version of Tremfya ...
The phase 3 SERENA-6 study randomised patients with HR-positive, HER2-negative advanced breast cancer whose tumours had an ...
NHS England has announced that it has appointed Sir James Mackey as its new chief executive officer (CEO), following Amanda ...
Amgen’s Blincyto (blinatumomab) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat ...
A 2024 ICON survey of over 100 oncology developers’ pipelines reflected a diverse and highly complex landscape of emerging ...
Global healthcare communications company Porterhouse Medical has announced the appointment of Michael Tague as president of ...
The US Food and Drug Administration (FDA) has approved Mirum Pharmaceuticals’ Ctexli (chenodiol) to treat adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results